4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-15-059931
Director sold 6,774 shares at $6.22 ($42,122)
- Director acquired 6,774 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2015-10-15 | Option exercise | +6,774 | $0.88 | $5,927 | 62,520 | D: show line 1 in the form |
| Kraus Al Director | 2015-10-15 | Sale | −6,774 | $6.22 | $42,122 | 55,746 | D: show line 2 in the form |
| Open-market sales · 6,774 sh · avg $6.22 · $42,122 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kraus Al Director | 2015-10-15 | Option exercise · Stock Option | −10,000 | 0 | D: show line 3 in the form |
Loading xslF345X03/v422421_4.xml…